Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure

被引:80
作者
Hu, Tiancen [1 ]
Zhang, Yu [1 ]
Li, Lianwei [1 ]
Wang, Kuifeng [1 ]
Chen, Shuai [1 ]
Chen, Jing [1 ]
Ding, Jianping [2 ]
Jiang, Hualiang [1 ]
Shen, Xu [1 ]
机构
[1] Chinese Acad Sci, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
[2] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China
关键词
SARS coronavirus; 3C-like protease; Dimerization; Enzymatic activity; Mutation; Monomer; ACUTE-RESPIRATORY-SYNDROME; PAPAIN-LIKE PROTEASE; COV MAIN PROTEINASE; DIMERIZATION; IDENTIFICATION; PURIFICATION; DISSOCIATION; CATALYSIS; ENZYME; BIOSYNTHESIS;
D O I
10.1016/j.virol.2009.03.034
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The 3C-like protease of SARS coronavirus (SARS-CoV 3CL(pro)) is vital for SARS-CoV replication and is a promising drug target. It has been extensively proved that only the dimeric enzyme is active. Here we discovered that two adjacent mutations (Ser139_Ala and Phe 140_Ala) on the dimer interface resulted in completely different crystal structures of the enzyme, demonstrating the distinct rates of these two residues in maintaining the active conformation of SARS-CoV 3CL(pro). S139A is a monomer that is structurally similar to the two reported monomers G11A and R298A. However, this mutant still retains a small fraction of dimer in solution, which might account for its remaining activity. F140A is a dimer with the most collapsed active pocket discovered so far, well-reflecting the stabilizing role of this residue. Moreover, a plausible dimerization mechanism was also deduced from structural analysis. Our work is expected to provide insight on the dimerization-function relationship of SARS-CoV 3CL(pro). (c) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:324 / 334
页数:11
相关论文
共 53 条
[1]   Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs [J].
Anand, K ;
Ziebuhr, J ;
Wadhwani, P ;
Mesters, JR ;
Hilgenfeld, R .
SCIENCE, 2003, 300 (5626) :1763-1767
[2]   Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α-helical domain [J].
Anand, K ;
Palm, GJ ;
Mesters, JR ;
Siddell, SG ;
Ziebuhr, J ;
Hilgenfeld, R .
EMBO JOURNAL, 2002, 21 (13) :3213-3224
[3]   Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro [J].
Bacha, U ;
Barrila, J ;
Velazquez-Campoy, A ;
Leavitt, SA ;
Freire, E .
BIOCHEMISTRY, 2004, 43 (17) :4906-4912
[4]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[5]   The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity [J].
Barretto, N ;
Jukneliene, D ;
Ratia, K ;
Chen, ZB ;
Mesecar, AD ;
Baker, SC .
JOURNAL OF VIROLOGY, 2005, 79 (24) :15189-15198
[6]  
Barretto N, 2006, ADV EXP MED BIOL, V581, P37
[7]   Long-range cooperative interactions modulate dimerization in SARS 3CLpro [J].
Barrila, Jennifer ;
Bacha, Usman ;
Freire, Ernesto .
BIOCHEMISTRY, 2006, 45 (50) :14908-14916
[8]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[9]   Reversible unfolding of the severe acute respiratory syndrome coronavirus main protease in guanidinium chloride [J].
Chang, Hui-Ping ;
Chou, Chi-Yuan ;
Chang, Gu-Gang .
BIOPHYSICAL JOURNAL, 2007, 92 (04) :1374-1383
[10]   Only one protomer is active in the dimer of SARS 3C-like proteinase [J].
Chen, Hao ;
Wei, Ping ;
Huang, Changkang ;
Tan, Lei ;
Liu, Ying ;
Lai, Luhua .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (20) :13894-13898